Acne

Data showed that the greatest improvement before and after acne care was achieved after medical treatment by a dermatologist.

Dr. Hawryluk noted that acne is estimated to affect 35%-95% of pediatric patients worldwide, though proper diagnosis and treatment of this dermatological condition is possible.

Studies are needed to determine the best treatment regimen for these patients.

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.

All patients treated with 2.5 benzoyl peroxide and a stabilized cosmetic retinol saw significant improvement in lesion count reduction after 12 weeks.

Patients with acne who receive isotretinoin treatment can expect a four- to five-fold improvement from baseline to follow-up in quality of life.

A dermatologist and clinical associate professor of dermatology discusses implementing telehealth in dermatology practices.

The new topical lotion is aimed at treating patients at least 9 years old with acne vulgaris.

AKLIEF Cream, a topical cream to treat acne on the face and trunk, is expected to be available in the US in November.

After a decade-plus, the risk management reduction program is not associated with a direct drop in at-risk pregnancies.

Recommendations for acne treatment drawn from AAD position paper and presentations.

The nodular acne therapy has been a staple treatment for 3 decades, yet new AAD data showed it could still be better utilized in patients.

A new, long-term assessment of phase 4 data shows a twice-daily regimen of the common acne therapy can retain patient benefits weeks after treatment ends.

Compared to standard cleansers and moisturizers, natural versions for sensitive skin provided benefits to patients with rosacea who were also taking prescription treatments.

An internist’s perspective on which sessions to attend, from melanoma to inflammatory diseases to cosmetic procedures.

A meta-analysis of studies found that treatment with platelet-rich plasma improves androgenetic alopecia, scarring, and other dermatologic conditions.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

Overall antibiotic prescriptions have dropped, but short-term postoperative prescriptions have increased in recent years.

In a pivotal phase 3 trial, patients' absolute change in facial inflammatory lesion counts included a least squares mean difference of -5.2 compared to those on placebo.

Altreno is a lotion containing .05% tretinoin, a retinoid that reduces inflammation and lesions associated with acne vulgaris.

Researchers initiated a new phase 3 clinical trial for topical agent olumacostat glasaretil, a potential treatment for acne vulgaris.

While cleansers and other at-home face masks can do wonders for acne and facial scarring, home remedies for skin cancer should be avoided at all costs.

Although popular acne treatment isotretinoin (Accutane) has been known to cause birth defects, many women still fail to follow simple contraception rules.

It has become unnecessary for dermatologists to request monthly lab tests for patients administered standard doses of isotretinoin for the treatment of severe acne.

Researchers reported that treatment with isotretinoin is not only associated with significant clinical improvement in patients with moderate to severe acne, but it also did not cause worsening of depression or suicidal thoughts in any of the patients in the study.